Kaken Pharmaceutical Co., Ltd. (4521.T)
JPY 4026.0
(1.21%)
JPY 4026.0
(1.21%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 29.02 Billion JPY | -9.02% |
| 2022 | 31.55 Billion JPY | 28.75% |
| 2021 | 24.5 Billion JPY | 6.03% |
| 2020 | 23.11 Billion JPY | -3.55% |
| 2019 | 23.96 Billion JPY | -17.94% |
| 2018 | 29.2 Billion JPY | 2.38% |
| 2017 | 28.52 Billion JPY | 6.68% |
| 2016 | 26.74 Billion JPY | 0.96% |
| 2015 | 26.48 Billion JPY | -7.07% |
| 2014 | 28.5 Billion JPY | 2.14% |
| 2013 | 27.9 Billion JPY | 1.59% |
| 2012 | 27.46 Billion JPY | 14.56% |
| 2011 | 23.97 Billion JPY | -0.67% |
| 2010 | 24.13 Billion JPY | -4.83% |
| 2009 | 25.36 Billion JPY | 0.32% |
| 2008 | 25.28 Billion JPY | 1.89% |
| 2007 | 24.81 Billion JPY | 0.21% |
| 2006 | 24.76 Billion JPY | 1.73% |
| 2005 | 24.34 Billion JPY | -2.1% |
| 2004 | 24.86 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 7.3 Billion JPY | -49.5% |
| 2023 Q1 | 6.76 Billion JPY | -49.5% |
| 2023 FY | 28.7 Billion JPY | -9.02% |
| 2023 Q4 | 8.03 Billion JPY | 18.59% |
| 2023 Q3 | 6.77 Billion JPY | -8.93% |
| 2023 Q2 | 7.44 Billion JPY | 10.1% |
| 2022 Q4 | 13.38 Billion JPY | 123.49% |
| 2022 Q1 | 5.98 Billion JPY | -6.24% |
| 2022 Q2 | 6.19 Billion JPY | 3.54% |
| 2022 Q3 | 5.99 Billion JPY | -3.29% |
| 2022 FY | 31.55 Billion JPY | 28.75% |
| 2021 Q1 | 5.85 Billion JPY | -6.58% |
| 2021 Q2 | 6.1 Billion JPY | 4.37% |
| 2021 Q3 | 6.16 Billion JPY | 0.98% |
| 2021 Q4 | 6.38 Billion JPY | 3.44% |
| 2021 FY | 24.5 Billion JPY | 6.03% |
| 2020 Q3 | 5.74 Billion JPY | -0.07% |
| 2020 FY | 23.11 Billion JPY | -3.55% |
| 2020 Q2 | 5.75 Billion JPY | 7.38% |
| 2020 Q1 | 5.35 Billion JPY | -11.85% |
| 2020 Q4 | 6.26 Billion JPY | 9.01% |
| 2019 Q4 | 6.07 Billion JPY | 5.73% |
| 2019 Q1 | 6.11 Billion JPY | -16.21% |
| 2019 Q2 | 6.02 Billion JPY | -1.52% |
| 2019 Q3 | 5.74 Billion JPY | -4.65% |
| 2019 FY | 23.96 Billion JPY | -17.94% |
| 2018 FY | 29.2 Billion JPY | 2.38% |
| 2018 Q4 | 7.3 Billion JPY | 8.72% |
| 2018 Q3 | 6.71 Billion JPY | -2.2% |
| 2018 Q1 | 8.31 Billion JPY | 6.21% |
| 2018 Q2 | 6.86 Billion JPY | -17.42% |
| 2017 Q2 | 6.82 Billion JPY | 0.46% |
| 2017 Q4 | 7.83 Billion JPY | 10.72% |
| 2017 Q3 | 7.07 Billion JPY | 3.6% |
| 2017 Q1 | 6.79 Billion JPY | 2.3% |
| 2017 FY | 28.52 Billion JPY | 6.68% |
| 2016 Q2 | 6.83 Billion JPY | -1.47% |
| 2016 Q3 | 6.32 Billion JPY | -7.45% |
| 2016 Q4 | 6.64 Billion JPY | 5.01% |
| 2016 FY | 26.74 Billion JPY | 0.96% |
| 2016 Q1 | 6.93 Billion JPY | -0.46% |
| 2015 Q3 | 6.4 Billion JPY | -2.24% |
| 2015 Q4 | 6.96 Billion JPY | 8.77% |
| 2015 FY | 26.48 Billion JPY | -7.07% |
| 2015 Q2 | 6.55 Billion JPY | -0.03% |
| 2015 Q1 | 6.55 Billion JPY | -18.65% |
| 2014 Q2 | 7.13 Billion JPY | 5.72% |
| 2014 Q3 | 6.55 Billion JPY | -8.15% |
| 2014 Q4 | 8.05 Billion JPY | 22.94% |
| 2014 FY | 28.5 Billion JPY | 2.14% |
| 2014 Q1 | 6.75 Billion JPY | -3.8% |
| 2013 Q4 | 7.01 Billion JPY | 0.86% |
| 2013 FY | 27.9 Billion JPY | 1.59% |
| 2013 Q1 | 6.86 Billion JPY | -0.42% |
| 2013 Q2 | 7.06 Billion JPY | 2.81% |
| 2013 Q3 | 6.95 Billion JPY | -1.46% |
| 2012 Q2 | 5.67 Billion JPY | 8.42% |
| 2012 FY | 27.46 Billion JPY | 14.56% |
| 2012 Q1 | 5.23 Billion JPY | -27.58% |
| 2012 Q3 | 9.65 Billion JPY | 70.01% |
| 2012 Q4 | 6.89 Billion JPY | -28.57% |
| 2011 Q4 | 7.23 Billion JPY | 25.79% |
| 2011 Q1 | 5.35 Billion JPY | -25.82% |
| 2011 Q2 | 5.64 Billion JPY | 5.5% |
| 2011 Q3 | 5.75 Billion JPY | 1.88% |
| 2011 FY | 23.97 Billion JPY | -0.67% |
| 2010 Q1 | 5.46 Billion JPY | -29.33% |
| 2010 Q4 | 7.21 Billion JPY | 32.23% |
| 2010 Q3 | 5.45 Billion JPY | -9.27% |
| 2010 Q2 | 6.01 Billion JPY | 10.07% |
| 2010 FY | 24.13 Billion JPY | -4.83% |
| 2009 Q2 | 5.94 Billion JPY | 1.26% |
| 2009 Q3 | 5.81 Billion JPY | -2.22% |
| 2009 Q4 | 7.72 Billion JPY | 32.92% |
| 2009 FY | 25.36 Billion JPY | 0.32% |
| 2009 Q1 | 5.87 Billion JPY | -26.55% |
| 2008 Q4 | 7.99 Billion JPY | 37.18% |
| 2008 FY | 25.28 Billion JPY | 1.89% |
| 2008 Q3 | 5.82 Billion JPY | -0.99% |
| 2008 Q2 | 5.88 Billion JPY | 0.0% |
| 2007 FY | 24.81 Billion JPY | 0.21% |
| 2006 FY | 24.76 Billion JPY | 1.73% |
| 2005 FY | 24.34 Billion JPY | -2.1% |
| 2004 FY | 24.86 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | 33.486% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 98.891% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 94.646% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 85.313% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -676.853% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 55.774% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 94.554% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -449.527% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 55.89% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | 37.264% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -151.242% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -252.6% |
| Tsumura & Co. | 48.8 Billion JPY | 40.52% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | 12.898% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | -48.569% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | 54.459% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -129.328% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | 28.268% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | 36.059% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -598.244% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -388.242% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -455.768% |
| MedRx Co., Ltd | 959 Million JPY | -2926.694% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -910.047% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -1866.531% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -1124.382% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | -20.116% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | 18.082% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -3848.143% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 70.921% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -1185.88% |